Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
The bill exempts from schedule I a prescription drug product containing the schedule I controlled substance (product) if the product is:Approved for prescription use by the United States food and drug administration; andDesignated or rescheduled by the United States drug enforcement agency (DEA).The exemption applies upon the DEA's designation or rescheduling.The bill requires that the product be controlled in Colorado in the same manner as the product is controlled by the DEA.(Note: This summary applies to this bill as introduced.)
Introduced
Feb 25, 2026
Last Action
Jan 22, 2026
Session
CO 2026A
Sponsors
4 primary · 3 co
Introduced In House - Assigned to Health & Human Services
Senate Third Reading Passed - No Amendments
Senate Second Reading Passed with Amendments - Committee, Floor
Senate Second Reading Laid Over to 02/23/2026 - No Amendments
Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole
Senate Committee on Health & Human Services Witness Testimony and/or Committee Discussion Only
Introduced In Senate - Assigned to Health & Human Services
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Introduced In Senate - Assigned to Health & Human Services
W. Lindstedt
J. Rich
S. Camacho
M. Soper
J. Bridges
J. Coleman
N. Hinrichsen